MKSI:NGS-MKS Instruments Inc. (USD)

EQUITY | Scientific & Technical Instruments | Nasdaq Global Select

Last Closing

USD 131.01

Change

+2.48 (+1.93)%

Market Cap

USD 3.08B

Volume

0.89M

Analyst Target

USD 148.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

MKS Instruments Inc is engaged in providing instruments, subsystems and process control solutions that measure, control, power, monitor and analyze critical parameters of manufacturing processes to improve process performance and productivity.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-24 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
GRMN Garmin Ltd

N/A

USD 31.36B
FTV Fortive Corp

N/A

USD 25.70B
KEYS Keysight Technologies Inc

N/A

USD 23.74B
TDY Teledyne Technologies Incorpor..

N/A

USD 18.41B
COHR Coherent Inc

N/A

USD 9.85B
VNT Vontier Corp

N/A

USD 6.04B
ST Sensata Technologies Holding N..

N/A

USD 5.92B
BMI Badger Meter Inc

N/A

USD 5.48B
ESE ESCO Technologies Inc

N/A

USD 2.72B
VPG Vishay Precision Group Inc

N/A

USD 0.42B

ETFs Containing MKSI

AZTD Aztlan Global Stock Selec.. 4.24 % 0.00 %

N/A

USD 0.04B
LADR:XETRA L&G Optical Technology & .. 3.68 % 0.00 %

N/A

USD 2.91M
FKU:LSE First Trust United Kingdo.. 2.32 % 0.00 %

N/A

USD 6.62M
FKUD:LSE First Trust United Kingdo.. 2.32 % 0.00 %

N/A

USD 2.31M
CUKS:LSE iShares VII PLC - iShares.. 1.90 % 0.00 %

N/A

USD 0.17B
SXRD:F iShares VII Public Limite.. 1.84 % 0.00 %

N/A

USD 0.17B
SXRD:XETRA iShares VII PLC - iShares.. 1.84 % 0.00 %

N/A

USD 0.18B
QTUM Defiance Quantum 1.81 % 0.65 %

N/A

USD 0.28B
CSUKS:SW iShares VII PLC - iShares.. 1.63 % 0.00 %

N/A

USD 0.18B
CEM:PA Amundi MSCI Europe Small .. 0.70 % 0.00 %

N/A

USD 0.04B
XXSC:LSE db x-trackers MSCI Europe.. 0.58 % 0.00 %

N/A

USD 1.87B
SMC:PA SPDR MSCI Europe Small Ca.. 0.48 % 0.00 %

N/A

USD 0.19B
SMCX:SW SPDR® MSCI Europe Small .. 0.48 % 0.00 %

N/A

USD 0.19B
SCZ iShares MSCI EAFE Small-C.. 0.29 % 0.39 %

N/A

USD 9.66B
FSYD Fidelity Sustainable High.. 0.04 % 0.00 %

N/A

USD 0.02B
FKU First Trust United Kingdo.. 0.00 % 0.80 %

N/A

USD 0.07B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.10B
RTLA 0.00 % 0.00 %

N/A

N/A
SCAP Series Portfolios Trust -.. 0.00 % 0.90 %

N/A

USD 3.04M
SIZ 0.00 % 1.71 %

N/A

N/A
TWOK 0.00 % 0.10 %

N/A

N/A
EXH8:F iShares (DE) I - iShares .. 0.00 % 0.00 %

N/A

USD 0.01B
EXH8:XETRA iShares (DE) I - iShares .. 0.00 % 0.00 %

N/A

USD 0.01B
AVDV Avantis® International S.. 0.00 % 0.00 %

N/A

USD 6.02B
HMCX:PA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.35% 77% C+ 93% A
Dividend Return 0.43% 71% C- 23% F
Total Return 27.78% 77% C+ 93% A
Trailing 12 Months  
Capital Gain 31.69% 69% C- 82% B
Dividend Return 0.88% 71% C- 9% A-
Total Return 32.58% 69% C- 81% B-
Trailing 5 Years  
Capital Gain 76.18% 70% C- 79% B-
Dividend Return 5.73% 60% D- 18% F
Total Return 81.91% 70% C- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.77% 77% C+ 69% C-
Dividend Return 10.52% 77% C+ 65% D
Total Return 0.75% 71% C- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 41.07% 15% F 25% F
Risk Adjusted Return 25.62% 62% D 46% F
Market Capitalization 3.08B 69% C- 82% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Scientific & Technical Instruments) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.30 25% 16%
Price/Book Ratio 3.33 46% 26%
Price / Cash Flow Ratio 27.00 23% 11%
Price/Free Cash Flow Ratio -10.53 100% 91%
Management Effectiveness  
Return on Equity -51.90% 23% 8%
Return on Invested Capital -17.60% 23% 8%
Return on Assets 3.10% 31% 56%
Debt to Equity Ratio 189.97% 20% 18%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector